Work

25P Evaluation of PD-L1 and Ki67 markers in CTCs of NSCLC patients treated with pembrolizumab

Year: 2021

Type: article

Source: Journal of Thoracic Oncology

DOI: 10.1016/s1556-0864(21)01867-0

Authors: M. Spiliotaki, H. Charalambous, C.M. Neophytou, G. Gregoriou, P. Vogazianos, C. Deltas, A.I. Constantinou

Institutions: University of Cyprus, Bank of Cyprus Oncology Center, European University Cyprus

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: Research and Innovation Foundation

OpenAlex ID: W3143711381

FWCI:

Cites:

Cited by:

Related to: 10